Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1973-6-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-3549
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
I
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:4699002-Advertising as Topic,
pubmed-meshheading:4699002-Humans,
pubmed-meshheading:4699002-Legislation, Drug,
pubmed-meshheading:4699002-Nonprescription Drugs,
pubmed-meshheading:4699002-Pharmaceutical Preparations,
pubmed-meshheading:4699002-Pharmacy,
pubmed-meshheading:4699002-Self Medication,
pubmed-meshheading:4699002-United States,
pubmed-meshheading:4699002-United States Food and Drug Administration
|
pubmed:year |
1973
|
pubmed:articleTitle |
OTC's: end the dual standard.
|
pubmed:publicationType |
Journal Article
|